Market Access Transformation, a Genesis Research company
Dr. Karen Mark has extensive experience in market access and clinical pharmacy. Currently serving as an Analyst in Market Access at Genesis Research Group, Dr. Mark supports clients in the biopharmaceutical and investment sectors through Rapid Payer Response engagements. Prior roles include Analyst in Market Access at Market Access Transformation, where research focused on product commercial viability, and Senior Content Analyst at Clarivate, overseeing Health Technology Assessment coverage and regulatory information management. Earlier experience includes internships at Kasturba Medical College and Max Super Specialty Hospital, where responsibilities involved evaluating medication therapy and providing evidence-based recommendations. Dr. Mark holds a Doctor of Pharmacy (PharmD) from Manipal Academy of Higher Education.
This person is not in any offices
Market Access Transformation, a Genesis Research company
**May 2022 Genesis Research acquired Marketing Access Transformation** Founded in 2016, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange insights that asses the real-world potential of their pharmaceutical products. With close to 65 employees that span the US, UK and India, MAT is seen as a revolutionary company in the global pharmaceutical research space. Our primary platform, Rapid Payer Responses™ (RPR), enables pharmaceutical manufacturers to conduct critical market access research throughout the product and treatment development process. Through our global, vetted payer network, it is possible to gather more accurate, robust feedback and insights by probing further and asking deeper questions. you always have the exact answers you need in a fraction of the time and cost of a traditional payer research project. Our life science experts help facilitate this process, monitoring the responses in real time as they come in for quality and detail. Since the launch of Rapid Payer Response™ (RPR) in July 2016, we have partnered with over 50 of the leading pharmaceutical manufacturers, expanded our payer network to more than 45 countries and have achieved an impressive 93% license renewal rate as we continue to disrupt the older and outdated models for payer research. Were are diverse minded, global company with offices in the US (NJ, NY & CA), UK and India. If you are interested in joining our amazing MAT team, check our openings at https://www.marketaccesstransformation.com/careers